Syndax Pharmaceuticals In... (SNDX)
15.56
-0.08 (-0.51%)
At close: Mar 03, 2025, 3:59 PM
15.48
-0.50%
After-hours: Mar 03, 2025, 04:00 PM EST
Syndax Pharmaceuticals Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Net Income | -209.36M | -149.34M | 24.93M | -73.16M | -56.05M | -73.96M | -60.8M | -44.47M | -24.12M | -19.83M | -14.17M | -9.96M | -13.09M |
| Depreciation & Amortization | 12K | 33K | 43K | 89K | 92K | 78K | 76K | 89K | 21K | 15K | 13K | 34K | 51K |
| Stock-Based Compensation | 30.95M | 16.02M | 13.32M | 9.06M | 6M | 6.2M | 5.45M | 4.71M | 3.88M | 2.26M | 1.42M | 139K | n/a |
| Other Working Capital | 26.25M | 2.98M | -11.76M | -5.26M | -4.98M | 490K | 7.87M | 1.99M | 13.52M | 1.28M | 317K | 858K | 467K |
| Other Non-Cash Items | -14.06M | -2.04M | 187K | 816K | 359K | 11K | 8K | 25K | 762K | 40K | 3.73M | 3.13M | 2.88M |
| Deferred Income Tax | n/a | n/a | 255K | -130K | -780K | -558K | 223K | 1.58M | 2.47M | 2.57M | 1.69M | -3.44M | n/a |
| Change in Working Capital | 31.86M | 1.66M | -9.6M | -7.93M | -241K | -302K | 7.67M | 2.92M | 14.56M | 551K | 31K | 823K | 141K |
| Operating Cash Flow | -160.6M | -133.68M | 29.13M | -71.26M | -50.61M | -68.53M | -47.37M | -35.16M | -2.43M | -14.39M | -7.29M | -9.28M | -10.02M |
| Capital Expenditures | n/a | -225K | -129K | n/a | n/a | -187K | -84K | -261K | -49K | -4K | -38K | -11K | -8K |
| Acquisitions | n/a | 225K | 40.74K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -354.61M | -495.35M | -294.72M | -278.94M | -104.02M | -78.84M | -152.26M | -158.32M | -102.01M | -3.39M | -4.02M | n/a | -500K |
| Sales Maturities Of Investments | 472.21M | 308.93M | 253.97M | 136.41M | 116.8M | 130.43M | 135.28M | 140.3M | 40.51M | 5.29M | n/a | 500K | 2.75M |
| Other Investing Acitivies | n/a | 225K | -40.74K | -142.53K | 12.78K | 51.59K | 45K | -97K | -118K | -1K | 33K | 5K | -50K |
| Investing Cash Flow | 117.61M | -186.19M | -40.87M | -142.53M | 12.78M | 51.4M | -17.03M | -18.38M | -61.67M | 1.89M | -4.03M | 494K | 2.19M |
| Debt Repayment | n/a | -21M | n/a | 19.73M | n/a | n/a | n/a | n/a | -9M | 14M | -3.68M | 6.31M | 8.63M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.6M | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 6.04M | 11.86M | 32.13M | 6.63M | 360K | 232K | 374K | 4.65M | 86.27M | -1.59M | 50.68M | -597K | n/a |
| Financial Cash Flow | 264.13M | 172.25M | 118.46M | 304.42M | 28.57M | 15.73M | 75.72M | 54.2M | 77.27M | 12.41M | 20.89M | 5.71M | 8.63M |
| Net Cash Flow | 221.14M | -147.61M | 106.72M | 90.63M | -9.26M | -1.4M | 11.32M | 665K | 13.17M | -95K | 9.57M | -3.08M | n/a |
| Free Cash Flow | -160.6M | -133.9M | 29M | -71.26M | -50.61M | -68.72M | -47.45M | -35.42M | -2.48M | -14.4M | -7.33M | -9.29M | -10.03M |